Healthcare Industry News: Wyeth
News Release - February 22, 2007
Wyeth Pharmaceuticals Announces Organizational Change
COLLEGEVILLE, Pa., Feb. 22 (HSMN NewsFeed) -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), announced today the appointment of Geno Germano, 46, to President - U.S. and General Manager, Wyeth Pharmaceuticals. In this new role, Mr. Germano will continue to report to Mr. Joseph Mahady, newly appointed President - Global Business, Wyeth Pharmaceuticals and Senior Vice President, Wyeth.Mr. Germano joined Wyeth in 1984 as a sales representative and has held positions of increasing responsibility in Sales, Marketing, Business Development and General Management, including Managing Director, Wyeth Australia and New Zealand; Executive Vice President and General Manager for Wyeth Global Vaccines; and most recently, Executive Vice President, Pharmaceutical Business Unit.
Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company's major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
Source: Wyeth Pharmaceuticals
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.
RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!